Novartis Q2 profits recover as revenue mantle passes to newer medicines
Despite a lacklustre start to the year, Novartis seems to have overcome its financial slump, reporting operating profits…
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market
This article first appeared on GuruFocus. Roche Holding (RHHBF) could be entering a new growth chapter after unveiling…